Shareholder ValueDepends how an investor interprets the deal. If you hold 100,000 Supreme shares the conversion equates to approximately 1,165 Canopy shares.
Supreme provides a fully operational facility which can produce 50,000 kg of premium product and 7 million tinctures, giving Canopy a great opportunity to expand the Kincardine facility due to the cash available. The premium product was the one segment which eluded Canopy from the start.
It is my understanding Canopy is aggressively pursuing the US and EU markets therefore if successful the stock could provide some growth, not the rocket ship Supreme investors were hoping for, but it could provide gradual growth if their recent acquisitions prove to be a success.
Penny stock investing is a cruel game, its extremely unpredictable and volatile, anything can happen. The manipulation was nauseating, I had never experienced anything like this before, but it appears to be within the confine of the law, therefore it is time to move on.
Thank you all for the sharing of information, and good luck in your future endeavours.